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Abstract
Human artificial chromosomes (HACs) have unique characteristics as gene-delivery vectors, including episomal transmission
and transfer of multiple, large transgenes. Here, we demonstrate the advantages of HAC vectors for reprogramming mouse
embryonic fibroblasts (MEFs) into induced pluripotent stem (iPS) cells. Two HAC vectors (iHAC1 and iHAC2) were
constructed. Both carried four reprogramming factors, and iHAC2 also encoded a p53-knockdown cassette. iHAC1 partially
reprogrammed MEFs, and iHAC2 efficiently reprogrammed MEFs. Global gene expression patterns showed that the iHACs,
unlike other vectors, generated relatively uniform iPS cells. Under non-selecting conditions, we established iHAC-free iPS
cells by isolating cells that spontaneously lost iHAC2. Analyses of pluripotent markers, teratomas and chimeras confirmed
that these iHAC-free iPS cells were pluripotent. Moreover, iHAC-free iPS cells with a re-introduced HAC encoding Herpes
Simplex virus thymidine kinase were eliminated by ganciclovir treatment, indicating that the HAC safeguard system
functioned in iPS cells. Thus, the HAC vector could generate uniform, integration-free iPS cells with a built-in safeguard
system.
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Introduction
Reprogramming somatic cells to become induced pluripotent
stem (iPS) cells is important in making regenerative medicine a
reality [1-3]. The best iPS cells for therapeutic applications are
derived from cells harvested from individual patients and the
reprogramming should not involve permanent genetic changes
because strategies involving insertional modifications of the
genome increase the risk of insertional mutagenesis [4] and
perturbation of differentiation potential [5]. To avoid permanent,
detrimental modification of the host genome while reprogram-
ming somatic cells, several vectors and protocols that exclude
permanent transgene integration into the host genome have been
developed: the piggyBac transposon [6-8], adenovirus vectors [9],
Sendai virus vectors [10], EB-derived episomal vectors [11] and
iterant administration of non-replicative materials (i.e. plasmid
[12], minicircle DNA [13], protein [14], and synthetic modified
mRNA [15]). However, these vectors and methods should be
scrutinized with regard to quality of individual iPS cells,
reprogramming efficiency and genome integrity. In addition, iPS
cells should have a safeguard system because iPS cells with
teratoma-forming potential can persist even after differentiation,
leading to unexpected and undesired events [16].
With respect to the generation of iPS cells, human artificial
chromosomes (HACs) have two important and unique character-
istics as gene-delivery vectors; effectively unlimited carrying
capacity for transgenic material and autonomous maintenance
through cell division that is independent of host chromosomes. We
have created several HAC vectors from human chromosome 21
using a top down method [17,18] and have demonstrated that full-
length genomic loci, such as DMD [19], HPRT [20] and p53 [20]
could be cloned into a defined HAC cloning site. We have also
shown that these loci are efficiently transcribed. Moreover,
expression in human cells of cDNAs introduced into HACs was
more stable and sustained and less subject to position effects [21]
than expression of cDNAs from conventional plasmids and viral
vectors. In addition, our HAC vectors encode EGFP [18];
therefore, because HACs are lost spontaneously at a low frequency
[22] we can isolate HAC-free cells from reprogrammed iPS
populations by identifying EGFP-negative cells.
Here, we have taken advantage of these features of HAC vectors
to generate vector-free and transgene-free iPS cells. Recent
attempts to generate iPS cells using polycistronic vectors to
express multiple proteins demonstrated that a significant portion of
the iPS clones carried more than two copies of the polycistronic
vector [6,8,23,24], suggesting that multiple copies of the
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we devised a reprogramming cassette with four defined repro-
gramming factors and introduced multiple copies of the cassette
into the cloning site of a HAC vector. We constructed a closely
related cassette by adding a p53 short hairpin RNA (shRNA)
expression construct to the four-factor cassette because suppression
of the p53 pathway leads to more efficient reprogramming [25-
29]. Moreover, our HAC vector encodes Herpes Simplex virus
thymidine kinase (HSV-TK), and we confirmed that iPS cells and/
or their differentiated derivatives carrying our HAC can be killed
by ganciclovir (GCV), providing a safeguard system if unexpected
events (e.g., tumor formation) occur.
Methods
Ethics Statement
All animal experiments were approved by the Institutional
Animal Care and Use Committee of Tottori University (the permit
number: 08-Y-69).
Plasmid construction
We constructed individual expression cassettes for each repro-
gramming factor in pBSII (Stratagene) and combined all cassettes
into a pPAC4 backbone as follows. The pBSII multiple cloning site
was replaced with either KpnI-XhoI-AscI-BsiWI-NheI-ClaI-SalI-
PstI-AvrII-PmeI-FseI-XbaI-SpeI-SacI or KpnI-XhoI-AscI-BsiWI-
NheI-ClaI-SalI-MluI-SphI-SnaBI-NotI-SacII-BamHI-AvrII-PmeI-
FseI-XbaI-SpeI-SacI, resulting in the vectors pB3 and pB4,
respectively. Two different 1.2 kb fragments of the chicken HS4
insulator were excised by either SacI or XbaI digestion of pCJ5-4 (a
gift from Dr. G. Felsenfeld, National Institutes of Health, Bethesda,
MD, USA), blunted by KOD polymerase (Toyobo), and cloned into
the SmaI site or the blunted HindIII site of pBSII, respectively. The
resulting vector, harboring 2 copies of HS4, was called pBSI-I. A
ClaI-BamHI fragment of pBSI-I was cloned into (1) a blunted ClaI
site of pB3, (2) a blunted ClaI site of pB4, or (3) blunted ClaI and
PmeI sites of pB4, resulting in (1) pinsB3, (2) pinsB4 and (3) pB4ins2,
all of which retained the BamHI site immediately downstream of the
HS4 dimer. All subcloned HS4 insulators had the same orientation.
Mouse Klf-4, c-Myc, Sox2 and Oct4 were PCR-amplified and
individually cloned into the EcoRI site of pCAGGS (a gift from Dr.
M. Okabe, Osaka University, Japan), resulting in pCX-Klf4, pCX-
c-Myc, pCX-Sox2 and pCX-Oct3/4, respectively. SalI-BamHI
fragments of pCX-Klf4, pCX-c-Myc and pCX-Sox2 were blunted
and cloned into blunted BamHI sites of pinsB4, resulting in pB4K,
pB4M and pB4S, respectively; an SspI-BamHI fragment of pCX-
Oct3/4 was cloned into a SnaBI site of pB4ins2, resulting in pB4O.
To combine four factors in a single vector, AscI-AvrII fragments
from pB4K and pB4S were inserted into the AscI-NheI sites of
pB4M and pB4O, resulting in pB4KM and pB4SO, respectively.
Finally, an AscI-AvrII fragment of pB4KM and an NheI-FseI
fragment of pB4SO were ligated into the AscI and FseI sites of
pPH3-9, which was generated by modifying pPAC4; specifically we
exchanged the region between the pUC link and the CMV
promoter with HPRT ex3-ex9 and added an FseI site immediately
downstream of HPRT ex9. The resulting vector was designated
pPAC-KMSO. This KMSO reprogramming cassette was dupli-
cated by the same strategy, resulting in pPAC-2CAG-KMSO. A
fragment of the duplicated pB4O was cloned into the AscI-NheI site
of pPAC-2CAG-KMSO, resulting in pPAC-2CAG-O2.
A mouse p53-knockdown construct was generated by annealing
two complementary synthetic oligonucleotides with the target
sequence GTACATGTGTAATAGCTCC and cloning the prod-
uct into the BglII-XbaI sites of pENTR4-H1 (a gift from Dr. H.
Miyoshi, RIKEN, Japan), resulting in pENTR4-H1-mp53sh. A
SalI-XbaI fragment of pENTR4-H1-mp53sh was inserted into the
SalI-AvrII site of pinsB3, resulting in pinsB3mp53sh. Finally, an
AscI-SpeI fragment of pinsB3mp53sh was inserted into the AscI-
NheI site of pPAC-2CAG-O2, resulting in pPAC-2CAG-
O2mp53sh.
Cell culture
Hprt-deficient Chinese hamster ovary cells(JCRB0218, JCRB Cell
Bank, Japan) each bearing a HAC vector, (CHO(21HAC2), CHO/
iHAC1/E15 and CHO/iHAC2/mp25) were maintained at 37uCi n
Ham’s F-12 nutrient mixture (Invitrogen) supplemented with 10%
f e t a lb o v i n es e r u m( F B S )a n d8 m/ml Blasticidin S (Funakoshi).
Mouse embryonic fibroblasts (MEFs), isolated from 13.5 day post-
coitum (d.p.c.) wild-type embryos (C57BL/6-J), were grown in
Dulbecco’s modified Eagle’s medium (DMEM) (Sigma) plus 10%
FBS. The mouse ES cell lines, TT2 (a gift from Dr. S. Aizawa,
RIKEN, Japan) [30] and B6ES (DAINIPPON SUMITOMO
PHARMA, Osaka, Japan), and the microcell hybrid clones, were
maintained on mitomycin C-treated Jcl:ICR (CLEA Japan) MEF
feeder layers in ES medium [DMEM with 18% FBS (Hyclone),
1 mM sodium pyruvate, 0.1 mM non-essential amino acids, 2 mM
L-glutamine (Invitrogen), 0.1 mM 2-mercaptoethanol (Sigma), and
1000 U/ml leukemia inhibitory factor (LIF) (Millipore)].
Construction of iHAC vectors
The reprogramming cassettes were introduced into 21HAC2
vectors using the Cre-loxP system. Suspensions of CHO(21HAC2)
cells (5 6 10
6 cells in PBS) were mixed with 10 mg of the Cre
expression plasmid (pBS185) and 20 mg of pPAC-2CAG-KMSO.
Electroporation was performed at 450 V and 500 mFu s i n ga
GenePulser Xcell (Bio-Rad). pBS185 (1 mg) and pPAC-2CAG-
O2mp53sh (2 mg) were transfected into semi-confluent CHO(21-
HAC2) cells in a 60 mm dish using Lipofectamine2000 (Invitrogen)
according to the manufacturer’s instructions. These cells were treated
with HAT (Sigma) and 8 mg/ml Blasticidin S two days after
transfection. After 2-3 weeks, drug-resistant colonies with a functional
HPRT allele were identified by genomic PCR and isolated.
Microcell-mediated chromosome transfer (MMCT) and
reprogramming of MEFs using iHAC vectors
MMCT was carried out as described previously [31]. CHO/
iHAC1/E15 and CHO/iHAC2/mp25 were used as microcell
donor cells. In brief, microcells were separated from donor cells by
centrifugation and fused with MEFs in 45% polyethyleneglycol
1500 (Roche) and 10% dimethylsulfoxide (Sigma). The next day,
fused cells were re-plated onto feeder layers. On day 2 and day 5, a
Figure 1. Construction of iHAC vectors. (A) A map of the reprogramming cassette constructed in a PAC vector, pPH3-9. The expression cassette
comprised cDNAs for Klf4, c-Myc, Sox2 and Oct4, each under the control of a CAG promoter and flanked with HS4 insulators. The reprogramming
cassette was followed by exon 3 to exon 9 of the human HPRT gene and then by a lox P site. (B) Schematic maps of the iHAC1 and iHAC2 inserts.
iHAC1 has a duplicated reprogramming cassette. iHAC2 has this duplicated cassette and an additional cassette with two copies of Oct4 and a p53
shRNA construct. (C) FISH analyses of CHO/iHAC1 and CHO/iHAC2. Digoxigenin-labeled human COT-1 DNA (red) was used to detect the HAC
backbone. Biotin-labeled pPAC-KMSO (green) was used to detect the reprogramming cassette in the iHACs. Chromosomal DNA was counterstained
with DAPI. White arrows indicate iHAC vectors and the insets show enlarged images of the iHACs.
doi:10.1371/journal.pone.0025961.g001
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transfected using DharmaFECT 1 (Dharmacon) according to the
manufacturer’s instructions. Culture medium was replaced with
ES medium on day 3, and individual ES-like colonies were isolated
from day 12 onwards.
FISH analysis
FISH analyses were performed on either fixed metaphase or
interphase spreads of each cell hybrid using digoxigenin-labeled
(Roche) human COT-1 DNA (Invitrogen) and biotin-labeled
pPAC-KMSO, essentially as described previously [31]. Images
were captured using the NIS-Elements system (Nikon). We
counted 20 metaphases and 100 interphases for each analysis.
M-FISH analysis
Procedures for the denaturation of metaphase chromosomes
and mFISH probes (MetaSystems), hybridization, post-hybridiza-
tion washes and fluorescent staining were performed in accor-
dance with the manufacturer’s instructions. Metaphase images
were captured digitally with a cooled CCD camera equipped with
an ISIS mFISH software program (MetaSystems), processed and
stored for subsequent analysis.
RT-PCR analysis
Total RNA was extracted with TriZol (Invitrogen) and cDNA was
synthesized using an oligo(dT) primer and ReverTra Ace (Toyobo).
Quantitative RT-PCR was performed using the Power SYBR Green
PCR Master Mix (Applied Biosystems) on an ABI7900HT (Applied
Biosystems). Primer sequences are listed in Table S1.
Immunohistochemistry
Cells were fixed with 4% paraformaldehyde in PBS at 4uC
overnight and permeabilized and blocked in 0.1% Triton X-100,
5% normal goat serum (Millipore) and 5% skim milk in PBS for 15
min at room temperature. Primary antibodies used were rabbit
anti-Nanog (1:100, AB5731, Millipore), mouse monoclonal anti-
Oct4 (1:100, sc-5279, Santa Cruz), rabbit anti-a-fetoprotein
(undiluted, N1501, Dako), mouse monoclonal anti-a-smooth
muscle actin (undiluted, N1584, Dako) and rabbit anti-bIII-
tubulin (1:2000, PRB-435P, Covance). Secondary antibodies used
were Alexa 594-conjugated goat anti-rabbit IgG (1:1000, Invitro-
gen) and Alexa 594-conjugated goat anti-mouse IgG (1:1000,
Invitrogen). Samples were counterstained with 1 m/ml DAPI. A
Leukocyte Alkaline Phosphatase Kit (Sigma) was used to detect
alkaline phosphatase activity.
Microarray analysis
Total RNA was prepared with the RNeasy midi Kit (Qiagen).
RNA (500 ng) was labeled with Cy3 using the Quick Amp
Labeling Kit (Agilent) according to the manufacturer’s instruc-
tions. cRNA was column-purified using the RNeasy Kit (Qiagen)
and hybridized to the Agilent Whole Mouse Genome Oligo
Microarray (G4122A). The data were normalized and analyzed
using GeneSpringGX11 (Agilent). Genes with a 4-fold change in
expression between MEFs and ESCs were selected and hierarchi-
cally clustered using the centroid linkage rule.
The microarray data is MIAME compliant and the raw data
have been submitted to the NCBI GEO database under the
accession number GSE29441.
In vitro differentiation mediated by embryoid body
formation
Cell suspensions were prepared by trypsinization and 500 cells
were aggregated in hanging drops of ES medium without LIF.
After 3 days, embryoid bodies (EBs) were seeded onto gelatin-
coated culture dishes for 4 days. Spontaneous germ-layer
differentiation of EBs was assayed using markers for endoderm
(AFP), mesoderm (a-SMA), and ectoderm (bIII-tubulin).
Teratoma formation
Approximately 1 610
6 cells were transplanted subcutaneously
into dorsal flanks of CD-1 (ICR)-nu mice (Charles River). Tumors
were isolated after 5-6 weeks and subjected to hematoxylin-eosin
staining. Histological examination confirmed differentiation into
all three germ layers.
Blastocyst injection
Chimera production was performed as described previously
[31]. Briefly, 4 lines of iHAC-free iPS cells (F-B1, F-C5, F-E4 and
F-N7) were separately injected into blastocyst-stage embryos
derived from ICR mice (CLEA Japan). Injected embryos were
then transferred into pseudopregnant ICR females.
Results
Construction of HAC-based cell-reprogramming vectors
To introduce four reprogramming factors into recipient cells
without the risk of integrating foreign genetic material into host
chromosomes, we constructed HAC-based cell-reprogramming
vectors. An expression cassette consisting of CAG promoter-driven
cDNAs of Klf4, c-Myc, Sox2 and Oct4, each surrounded by copies
Figure 2. Reprogramming MEFs with iHAC1 or iHAC2. (A) Flowchart of iPS cell generation after MMCT. We screened for cells reprogrammed by
iHAC vectors using two criteria: ES-like morphology and EGFP fluorescence. Packed domed colonies emerged 10 days after MMCT. After expansion,
EGFP-negative fractions were sorted from isolated clones to isolate iHAC-free cells. (B) Representative bright-field and fluorescence images of iHAC1-
and iHAC2-iPS clones obtained by MMCT. (C) FISH analyses of three lines, iHAC1-iPS 1-D6, iHAC2-iPS 2-N and iHAC-free iPS F-C5.
doi:10.1371/journal.pone.0025961.g002
Table 1. Summary of MMCT experiments to generate iPS cells from MEFs.
experiment No. HAC vector recipient EGFP+ colony ES-like clone HAC-abrogated clone
Exp.1 iHAC1 10
6 MEFs 7 4 (57%) 0 (0%)
Exp.2 iHAC2 10
6 MEFs 6 3 2
Exp.3 iHAC2 10
6 MEFs 15 10 5
Exp.2+3 21 13 (62%) 7 (33%)
doi:10.1371/journal.pone.0025961.t001
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vector to generate pPAC-KMSO (Fig. 1A). To achieve high
expression of these four reprogramming factors, the expression
cassette was duplicated, resulting in pPAC-2CAG-KMSO. To
generate a more effective reprogramming cassette, two additional
copies of CAG-driven Oct4 and an H1 promoter-driven p53
shRNA were inserted adjacent to the cassettes in pPAC-2CAG-
KMSO, resulting in pPAC-2CAG-O2mp53sh. We chose
21HAC2 from our series of 21HAC vectors to carry these
reprogramming cassettes because it encodes EGFP; therefore,
recipient cells could be screened for the presence of 21HAC2
derivatives via EGFP detection. pPAC-2CAG-KMSO or pPAC-
2CAG-O2mp53sh along with an expression plasmid encoding Cre
recombinase was introduced into a 21HAC2-carrying Hprt-
deficient Chinese Hamster Ovary (CHO) cell line, CHO(21-
HAC2) via co-transfection. Transformation was followed by
HAT/blasticidin double selection. The HAC vectors carrying
the expression cassettes from pPAC-2CAG-KMSO or pPAC-
2CAG-O2mp53sh were designated iHAC1 and iHAC2, respec-
tively (Fig. 1B). FISH, genomic PCR, and RT-PCR screens were
performed to select and verify two drug-resistant CHO donor
clones: CHO/iHAC1/E15 and CHO/iHAC2/mp25, which each
encoded a correctly reconstituted HPRT gene, stably expressed all
reprogramming factors and maintained the iHAC independently
from the host chromosomes (Fig. 1C and Fig. S1). These results
indicated that two iHACs (iHAC1 and iHAC2), designed to
reprogram somatic cells, were structured as intended in CHO
cells. These CHO cell lines can function as donor cells for
microcell-mediated chromosome transfer (MMCT) of the HACs
into mouse embryonic fibroblasts (MEFs).
Derivation of iPS cells from MEFs using the iHAC vectors
To assess the reprogramming ability of iHAC1 and iHAC2,
each was transferred from a CHO donor cell line into
approximately 10
6 MEFs via MMCT. A schematic of this process
is shown in Figure 2A. MEFs were re-plated onto a feeder layer
one day after MMCT and were treated with miR-294/295 mimics
on day 2 and day 5 to raise the efficiency of reprogramming.
EGFP-positive colonies with embryonic stem (ES) cell-like
morphology emerged on about day 10 and were selected on days
12-20 after MMCT. The reprogramming effects of iHAC2
became apparent somewhat earlier than those of iHAC1. We
obtained 7 and 21 EGFP-positive colonies from one iHAC1 and
two iHAC2 transfer experiments, respectively (Table 1). Of the 7
iHAC1 colonies, 4 were expandable, and subclones of these 4
colonies were established as iHAC1-iPS cells (Fig. 2B). iHAC2-iPS
subclones were also established from 13 of the 21 iHAC2 colonies.
All iHAC1-iPS lines expressed Nanog and Oct4 epitopes, were
alkaline phosphatase-positive (Fig. S2), and could form embryoid
bodies (EBs) that differentiated into three germ layers (Fig. S3).
Figure 3. Characterization of iPS cells generated by iHAC vectors. (A, C) Quantitative RT-PCR analysis of total and endogenous
reprogramming factor (Klf4, c-Myc, Sox2 and Oct4) expression in iHAC1- and iHAC2-iPS cells. Transcript levels for these genes relative to levels in B6ES
cells are shown, after normalization to Nat1 expression. (B, D) Quantitative RT-PCR analyses of pluripotency markers.
doi:10.1371/journal.pone.0025961.g003
Table 2. Characterization of iPS cells generated by the iHACs.
HAC vector iPS line subline copy no. of iHAC expression (qRT-PCR) differentiation microarray
transgene ES marker in vitro in vivo
iHAC1 1-A 1-A3 1 high low 3 germ layers no tumor Yes
1-A10 1 high low 3 germ layers no tumor N/D
1-B 1 high low 3 germ layers no tumor Yes
1-C 1-C3 1 high low 3 germ layers malignant Yes
1-C4 1 high low 3 germ layers no tumor N/D
1-D 1-D6 1 high low 3 germ layers malignant Yes
1-D10 1 high low 3 germ layers malignant N/D
iHAC2 2-A 2-A3 1 high moderate N/D N/D N/D
2-B 2-B1 1 high moderate N/D N/D Yes
2-C 2-C6 1 high moderate N/D N/D Yes
2-D 2 high moderate N/D N/D N/D
2-E 1 high moderate N/D N/D Yes
2-F 2 high moderate N/D N/D N/D
2-G translocated high moderate N/D N/D N/D
2-H 2 high moderate N/D N/D N/D
2-J 1 high moderate N/D N/D N/D
2-K 2 high moderate N/D N/D N/D
2-L 1 high moderate N/D N/D N/D
2-M 2 high moderate N/D N/D N/D
2-N 1 high moderate N/D N/D Yes
N/D not determined.
doi:10.1371/journal.pone.0025961.t002
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pluripotent markers were much lower in the iHAC1-iPS cells
than in ES cells. Moreover, expression of transgenic reprogram-
ming factors (Klf4, c-Myc, Sox2 and Oct4) in the iHAC1-iPS cells
was higher than that of their endogenous counterparts (Fig. 3A, B).
Most of the iHAC2-iPS lines expressed the pluripotent markers at
levels near to those of ES cells and were more completely
reprogrammed than were the iHAC1-iPS cells. Interestingly,
expression of the transgenic reprogramming factors in the iHAC2-
iPS cells, as in the iHAC1-iPS cells, was higher than that of the
endogenous counterparts (Fig. 3C, D). FISH analyses of the
iHAC-iPS lines revealed that there was one iHAC1 copy/cell in all
4 clones, and that 7 of the 13 iHAC2 clones had 1 iHAC2 copy/
cell, 4 had 2 copies/cell, and 1 had more than 2 copies/cell. These
16 iHAC-iPS clones maintained the iHACs independently of the
host chromosomes (Fig. 2C and Table 2). The iHAC2 vector was
translocated onto a host chromosome in only one iHAC2-iPS line.
These results indicated that a single copy of either iHAC induced
somatic cell reprogramming, and that iHAC2 was more effective
than iHAC1 in inducing this reprogramming. We also determined
whether supplementation by miR-294/295 mimics were required
to achieve somatic cell reprogramming by iHAC2, because the
pluripotent state of iHAC2-iPS cells was highly similar to that of
ES cells. Fourteen out of 22 EGFP-positive colonies (64%),
obtained from the iHAC2 transfer without miR-294/295 mimics,
expressed ground state pluripotency markers, Nanog and Rex1, at
levels similar to those of mouse ES cells (Table 3 and Fig. S4). In
the presence of miR-294/295 mimics, pluripotent clones appeared
at a frequency of 57% (8 out of 14 EGFP-positive colonies), similar
to that without these mimics. These results indicate that miR-294/
295 mimics are not necessary for somatic cell reprogramming by
the iHAC2 protocol.
Establishment of integration-free iPS cells
Sustained transgene expression can affect the function of iPS
cells and can lead to deleterious effects, such as tumorigenesis
[32,33]. Therefore, we established iHAC-free iPS clones from the
iHAC-iPS cells by isolating EGFP-negative clones. During host
cell division under non-selecting conditions, the HAC vectors are
lost spontaneously at a low frequency (1610
-5). An EGFP-negative
Table 3. Efficiency of iPS cell generation from MEFs using iHAC2 with or without miR-294/295.
experiment No. HAC vector recipient miR-294/295 EGFP+ colony clone ID pluripotent clone
Exp.4 iHAC2 10
6 MEFs - 15 A1 - A15 7
Exp.5 iHAC2 10
6 MEFs - 7 B1 - B7 7
Exp.4+5 22 14 (64%)
Exp.6 iHAC2 10
6 MEFs + 14 C1 - C14 8 (57%)
doi:10.1371/journal.pone.0025961.t003
Table 4. Characterization of iPS cells isolated from the GFP-negative population by FACS.
parental
clone
sorted
clone presence of HAC expression (qRT-PCR) differentiation chimera microarray
transgene ES marker in vitro in vivo
1-D6 S3 present high low 3 germ layers teratoma N/D N/D
S5 present high low 3 germ layers teratoma N/D N/D
S9 present high low 3 germ layers teratoma N/D N/D
S10 present high low 3 germ layers teratoma N/D N/D
2-B1 F-B1 absent none high 3 germ layers teratoma chimera Yes
F-B2 absent none high 3 germ layers teratoma N/D N/D
2-C6 F-C5 absent none high 3 germ layers teratoma chimera Yes
2-E F-E4 absent none high 3 germ layers teratoma chimera Yes
F-E8 absent none high 3 germ layers N/D N/D N/D
2-H F-H1 absent none high 3 germ layers N/D N/D N/D
F-H2 absent none high 3 germ layers teratoma N/D N/D
F-H3 absent none high 3 germ layers N/D N/D N/D
2-J F-J6 absent none high 3 germ layers N/D N/D N/D
F-J7 absent none high 3 germ layers teratoma N/D N/D
2-L F-L6 absent none high 3 germ layers N/D N/D N/D
2-N F-N7 absent none high 3 germ layers teratoma chimera Yes
F-N8 absent none high 3 germ layers N/D N/D N/D
F-N9 absent none high 3 germ layers N/D N/D N/D
N/D not determined.
doi:10.1371/journal.pone.0025961.t004
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5 cells)
was harvested by FACS (MoFlo XDP, Beckman Coulter), plated
onto a feeder layer, and re-cloned based on morphological criteria.
EGFP-negative colonies (n=4) were selected randomly and
assayed for the presence or absence of the iHAC1 vector. FISH
and genomic PCR analyses revealed that all 4 EGFP-negative
clones (clones S3, S5, S9 and S10) retained the iHAC1 vector
(Table 4), and qRT-PCR analysis indicated that all transgenes
were expressed (Fig. 3A). These results indicated that the iHAC1-
iPS cells were only partially reprogrammed and that their
pluripotent status was dependent on continued transgene expres-
sion from the iHAC1. Thus, iHAC1-free iPS lines were not
established from the iPS cells, and the EGFP-negative clones
probably resulted from epigenetic silencing of the EGFP gene. In
contrast, iHAC2-free iPS cells were isolated from 7 of the
original12 iHAC2-iPS clones by selecting for EGFP-negative cells.
The iHAC2 vector was not detected by FISH or genomic PCR in
14 sub-clones (Fig. 2C and Fig. 4A); therefore, we concluded that
the iHAC2 vector was absent from the EGFP-negative fractions of
the iPS cell lines. Cytogenetic analyses with Q-banding and M-
FISH confirmed that the iHAC2-free clones had a normal
karyotype (Fig. 4B). Furthermore, expression levels of the
endogenous reprogramming factors (Klf4, c-Myc, Sox2 and
Oct4) were similar in iHAC2-free clones and mouse ES cells
(Fig. 4C). These results are summarized in Table 4.
Pluripotency of iHAC-free iPS cells
To assess the pluripotent state of the iHAC-free iPS cells, we
performed qRT-PCR analyses using a variety of stem cell markers.
The iHAC-free iPS cells expressed 12 pluripotency markers,
including Sox2 and Oct4, at levels similar to those of mouse ES
cells (Fig. 4C, D). Furthermore, to assess whether absence of
transgenes enhanced the pluripotent state of the iHAC-iPS cells, we
compared the global gene expression profiles of mouse ES cells, the
iHAC1-iPS cells, the iHAC2-iPS cells, and the iHAC-free iPS cells.
Unsupervised hierarchical clustering and scatter plots showed that
the iHAC-free iPS cells were more similar to ES cells than to the
iHAC1-iPS cells and the iHAC2-iPS cells, and that the iHAC1-iPS
cells were most distant from ES cells (Fig. 5A, B). All 7 iHAC-free
iPS clones examined (F-B1, F-B2, F-C5, F-E4, F-H2, F-J7 and F-
N7) also had differentiation potential in both in vitro (EB-based) and
in vivo (teratoma) assays. Furthermore, 4 of 4 iHAC-free iPS clones
tested gave rise to live chimeras (Fig. 6A-C). Although it remains to
be determined whether germ line transmission in adult chimeras
occurs, it can be said that the iHAC-free iPS cells were pluripotent.
A safeguard system
Our 21HAC vectors carry a suicide gene, HSV-TK, to eliminate
cells with undesirable or unexpected phenotypes (e.g., tumor
development) [18]. To verify that this safeguard system functions
in iPS cells, we introduced a 21HAC2 vector into Duchenne
muscular dystrophy (DYS) model (mdx)-iPS cells previously
generated from MEFs of mdx mice by the retroviral transduction
of four reprogramming factors [34]. The mdx-iPS(DYS-HAC) cells
wereproduced by the transfection of 21HAC2, harboring HSV-TK,
and a full-length Dystrophin locus. GCV, administered consecu-
tively over 32 days, selectively repressed advancement of teratomas
from the mdx-iPS(DYS-HAC) cells, but not of control mdx-iPS
cells, and administration of PBS had no effect on either cell line (Fig.
S5). Next, we assessed the effects of GCV on iHAC-free iPS cells
(derived from the iHAC2-iPS cells) that were transferred with
21HAC2. The 21HAC2 was introduced into iHAC-free iPS clones
F-C5 and F-E4. Isolated iPS clones carrying 21HAC2 were tested
for sensitivity to GCV. The iPS clones exhibited in vitro growth
retardation in 5 mM GCV, which is the effective dosage for mouse
ES cells carrying 21HAC2 [18]. Advancement of a teratoma from
F-C5/21HAC2, but not from F-C5, was inhibited by consecutive
administrationofGCV(Fig.6D,E).Therefore,theHSV-TKsuicide
system of the HAC vectors operated in iPS cells that were generated
by either a retrovirus vector or the iHAC2 vector. In addition, the
iPS cells carrying 21HAC2 differentiated into all three germ layers
in the teratoma and contributed to chimera development (data not
shown), suggesting that the re-introduced 21HAC2 vector did not
affect the pluripotency of iPS cells.
Discussion
We demonstrate that a HAC vector containing expression
cassettes for four reprogramming factors and a p53-knockdown
construct efficiently reprogrammed somatic cells to pluripotency.
In addition, we established integration-free iPS cells derived from
these reprogrammed cells. Inserting all expression constructs into a
defined cloning site on the HAC vector, which was maintained
stably and independently of host chromosomes in cells, resulted in
homogenous expression levels of the transgenes in HAC donor
and recipient cells. Once configuration of an expression cassette in
the HAC vector is optimized for the generation of iPS cells, the
resulting uniformity of transgene expression in target cells is an
advantage in promoting reprogramming efficiency and reducing
clonal variation in the resulting iPS cells. Thus, the HAC-based
reprogramming strategies are expected to be more effective in
establishing homogenous iPS clones than other methods, including
DNA transfection and viral transduction, which are both unable to
regulate the quantity of xeno-products in modified cells.
Nonetheless, the transfer rate of HAC vectors via MMCT is
relatively low, i.e., 10
-5. To overcome this drawback, our protocol
was enhanced with two procedures. First, to sustain high
expression levels of individual reprogramming factors, each factor
was surrounded with insulators. Second, to potentiate the
reprogrammed state, miR294 cluster mimics, which promote
induced pluripotency [35], were added after MMCT. Indeed,
although the overall efficiency of reprogramming by our iHAC
strategy was approximately 0.001%, more than half of iHAC-
bearing cells developed an ES-like phenotype (iHAC1, 57%; and
iHAC2, 62%). Furthermore, vector-free, transgene-free iPS cells
were established from a third of the iHAC2-iPS lines. Notably, the
effect of iHAC2 on the generation of iPS cells was no longer
dependent on the addition of miR294 cluster mimics, because the
pluripotent state induced by iHAC2 alone was sufficiently high.
Therefore, the HAC vector system did facilitate somatic cell
reprogramming by homogenous expression of the transgenic
reprogramming factors and established vector-free, transgene-free
iPS cells, which are suitable for clinical applications. Nevertheless,
the MMCT frequency needs to improve. An improved MMCT
Figure 4. Establishment of iHAC-free iPS cells. (A) Genomic PCR of individual transgenes in cells from an EGFP-negative fraction of iHAC2-iPS
cells was compared with that of the parental clones. D8Mit224 was used as an internal control. (B) Cytogenetic analysis of iHAC-free iPS cells.
Representative karyotypes of iHAC-free iPS F-C5 (Q-banding) and F-N7 (M-FISH) show normal karyotypes after loss of iHAC2. (C) Quantitative RT-PCR
of total and endogenous reprogramming factor expression. (D) Quantitative RT-PCR of pluripotency markers. Transcript levels of 10 pluripotent genes
were normalized to Nat1; transcript levels in iHAC-free iPS cells were compared with those in B6ES cells.
doi:10.1371/journal.pone.0025961.g004
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iHAC (50-100 times) [36].
All iHAC1-iPS cells satisfied some criteria of pluripotency (e.g.,
alkaline phosphatase staining, EB formation, ability of EB cells to
differentiate into three germ layers); however, the iHAC1-iPS cells
expressed only low levels of various pluripotent markers, indicating
only partial reprogramming. In contrast, expression of pluripotent
markers in most of the iHAC2-iPS cells was significantly
upregulated and close to that in ES cells. These results were
consistentwithpreviousstudies,which demonstratedthatincreasing
Oct4 expression relative to the other three reprogramming factors
[37] and suppression of the p53 pathway [25-29] resulted in
enhanced reprogramming efficiency. Notably, in both iHAC1-iPS
and iHAC2-iPS cells, gene silencing of the transgenic reprogram-
ming factors was incomplete or nonexistent because each
reprogramming factor was surrounded by multiple copies of the
insulator. Moreover, expression levels of anti-proliferative genes in
the iHAC1-iPS and the iHAC2-iPS cells were similar to those in ES
cells,andwerenotupregulated(Fig. S6).Therefore,the majorcause
of the partial reprogramming in the iHAC1-iPS cells, but not the
iHAC2-iPS cells, may be inadequate activation of endogenous
pluripotent genes rather than sustained expression of transgenes or
induction of anti-proliferative genes. Recently, it has been
demonstrated that Nanog drives partially reprogrammed cells into
ground state pluripotency [38]. Therefore, we can assume that p53
shRNA and the additional copies of Oct4 encoded by iHAC2 may
have contributed to consolidating connections between core
transcription factor networks and the enhanced expression of genes
like Nanog [39]. This hypothesis is supported by the evidence that
supplementation of miR294/295 was no longer required for the
iHAC2 reprogramming protocol. These results indicate that
transgene integration into a defined cloning site on a HAC vector
may also be useful for screening other reprogramming factors that
improve the quality of iPS cells and increase overall efficiency.
Removal of potential obstacles, such as persistent exogenous genes
or chemicals, the maintenance of normal cellular functions and the
preservation of genome integrity are fundamental to the application
of iPS cells in regenerative medicine. Here, we demonstrated that a
HAC vector can mediate somatic cell reprogramming and that
transgene-free, vector-free iPScells can be obtained from iHAC2-iPS
cells using simple FACS sorting; in contrast, other systems require
prolonged culture, vector excision and drug selection to obtain
integration-free iPS cells. Furthermore, the iHAC-free iPS cells
generated using iHAC2 did not exhibit chromosomal aberrations,
Figure 5. Global gene expression analysis of iHAC1-, iHAC2-, and iHAC-free iPS cells. (A) Unsupervised hierarchical clustering of global
gene expression profiles from ES cells, iPS cells generated by retroviral or iHAC vectors, and MEFs. (B) Scatter plots of microarray data comparing ES
cell line B6ES to iHAC1-iPS 1-B, iHAC-free iPS F-B1 and retroviral iPS 20D17 cells. Highlighted marks indicate core pluripotent markers, Nanog, Oct4
and Sox2. Red lines indicate two-fold changes in expression between samples.
doi:10.1371/journal.pone.0025961.g005
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PLoS ONE | www.plosone.org 11 October 2011 | Volume 6 | Issue 10 | e25961Figure 6. Pluripotency of iHAC-free iPS cells and a HAC safeguard system. (A) in vitro differentiation mediated by EB formation. (B)
Representative images of various tissues present in teratomas derived from iHAC-free iPS F-C5 cells. (C) Live-born chimeras from iHAC-free iPS clones.
(D, E) Confirmation of the HAC safeguard system. Growth of iHAC-free iPS clones re-transformed with 21HAC2 or with a retroviral iPS clone harboring
DYS-HAC was inhibited by GCV in vitro (D). Parental iHAC-free iPS F-C5 and F-C5/21HAC2 were subcutaneously transplanted into nude mice. 30 mg/
kg GCV was then administered intraperitoneally for 24 consecutive days (E).
doi:10.1371/journal.pone.0025961.g006
Integration-Free iPSCs Using Artificial Chromosome
PLoS ONE | www.plosone.org 12 October 2011 | Volume 6 | Issue 10 | e25961although the present version of iHAC2 contained a p53-knockdown
construct. Thus, the strategy of using HAC vectors to generate
integration-free iPS cells might be valuable. Moreover, the HAC
vector itself was safe because it was maintained independently of host
chromosomes, and importantly, chimeric mice were produced from
mouse ES/iPS cells harboring a HAC vector [18,19,34]. We have
demonstrated that HAC vectors are able to carry therapeutic genes,
especially genomic loci larger than 1 Mb, and that they are able to
correct multiple cellular defects in target cells without transgene
integration [20,34]. As illustrated in Figure 7, our overall strategy for
regenerativemedicineusingHACvectorsequippedwithoneormore
suicide genes as a safeguard system may facilitate the generation of
patient-specific iPS cells that complement genetic traits causing
diseases without risking genomic alteration and other undesirable
outcomes.
Supporting Information
Figure S1 Transgene expression in CHO donor cells.
Expression of the four reprogramming factors contained in the
iHAC vectors was confirmed by RT-PCR. In qRT-PCR assays,
transcript levels of transgenes were standardized to Gapdh.
Transcript levels in CHO/iHAC2/mp25 were compared to levels
in CHO/iHAC1/E15.
(EPS)
Figure S2 Characterization of iHAC1-iPS cells. (A) Alka-
line phosphatase staining of iHAC1-iPS 1-A10, 1-C3, 1-D10 and
mouse ES TT2cells. (B, C) Immunostaining of pluripotent markers.
iPS cells with the iHAC1 vector and that were positive for EGFP
(green) were stained for Nanog (B) and Oct4 (C).
(EPS)
Figure S3 In vitro differentiation of iHAC1-iPS cells. (A)
EB formation. (B) Phase-contrast images showing differentiated
cells derived from EBs. (C) Immunostaining confirming that
iHAC1-iPS cells differentiated into each germ layer in vitro.
(EPS)
Figure S4 Expression levels of pluripotent markers,
Nanog and Rex1. Pluripotency of iHAC2-iPS cells generated
without miR-294/295 was compared to that of iHAC2-iPS cells
with miR-294/295 by quantitative RT-PCR analyses of Nanog and
Rex1 expression. Transcript levels were standardized to Nat1 and
normalized to B6ES cells.
(EPS)
Figure S5 Anti-proliferative effect of GCV on HSV-TK-
containing mdx-iPS(DYS-HAC) cells in vivo. Parental mdx-
iPS cells and mdx-iPS(DYS-HAC) cells were subcutaneously
transplanted into nude mice, then GCV was administered
intraperitoneally. Tumor volume was calculated using the formula
[width (mm)]6[length (mm)]6[depth (mm)]. Administration of
PBS was used as a control.
(EPS)
Figure S6 Expression levels of p53, Ink4a, Arf and Cip1.
Quantitative RT-PCR analyses of p53, Ink4a, Arf and Cip1 levels
in iHAC1- and iHAC2-iPS cells were compared with levels in
parental MEFs and mouse ES cells. Transcript levels were
standardized to Nat1 and normalized to B6ES cells.
(EPS)
Table S1 Primers used for PCR analyses.
(XLS)
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